Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01811849
What this trial is testing

Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Biodel 12
Early research (Phase 1)Looking for participantsNCT05470348
What this trial is testing

BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Who this might be right for
Breast CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 36
Post-approval studies (Phase 4)Study completedNCT02583399
What this trial is testing

Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

Who this might be right for
PainFever
Cumberland Pharmaceuticals 30
Early research (Phase 1)UnknownNCT06360874
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults

Who this might be right for
Healthy
Shenzhen NewDEL Biotech, Co., Ltd 104
Testing effectiveness (Phase 2)Study completedNCT01136174
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 50
Early research (Phase 1)Study completedNCT01788774
What this trial is testing

Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths

Who this might be right for
SchizophreniaSchizoaffective Disorder
Rovi Pharmaceuticals Laboratories 36
Testing effectiveness (Phase 2)Study completedNCT00340704
What this trial is testing

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Who this might be right for
Bladder, Neurogenic
Boehringer Ingelheim 143
Early research (Phase 1)Study completedNCT05396833
What this trial is testing

Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)

Who this might be right for
Metastatic or Locally Advanced Unresectable Solid Tumors
EMD Serono Research & Development Institute, Inc. 120
Early research (Phase 1)Ended earlyNCT00147485
What this trial is testing

An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer

Who this might be right for
NeoplasmsLymphoma, Non-Hodgkin
Pfizer 37
Early research (Phase 1)Study completedNCT02202408
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670

Who this might be right for
Endometriosis
SK Chemicals Co., Ltd. 16
Early research (Phase 1)Study completedNCT00981240
What this trial is testing

Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes

Who this might be right for
Acute Myelogenous Leukemia
Sanofi 30
Early research (Phase 1)Looking for participantsNCT07274852
What this trial is testing

Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Lung CancerBreast CancerHead and Neck Squamous Cell Carcinoma+1 more
Sichuan Baili Pharmaceutical Co., Ltd. 22
Early research (Phase 1)Looking for participantsNCT05461768
What this trial is testing

BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid Tumors

Who this might be right for
Breast CancerLocally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 348
Early research (Phase 1)Study completedNCT01777243
What this trial is testing

Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis

Who this might be right for
Amyloidosis
GlaxoSmithKline 25
Early research (Phase 1)Study completedNCT00583544
What this trial is testing

A Safety and Tolerability Single Ascending Dose Study in Healthy Volunteers

Who this might be right for
Healthy
Targacept Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00037609
What this trial is testing

Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients

Who this might be right for
Breast NeoplasmsMetastases, Neoplasm
M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT00591214
What this trial is testing

Safety and PK Study of MP-424 to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 10
Early research (Phase 1)Study completedNCT01138085
What this trial is testing

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

Who this might be right for
Cancer
GlaxoSmithKline 240
Early research (Phase 1)Study completedNCT01289899
What this trial is testing

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 16
Testing effectiveness (Phase 2)Looking for participantsNCT07140809
What this trial is testing

A Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia

Who this might be right for
Hypertriglyceridemia
Shanghai JMT-Bio Inc. 48
Next Page